Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes.

ABSTRACT:

Aim

Poor outcomes of coronavirus disease 2019 (COVID-19) have been linked to diabetes, but its relation to pre-infection glycaemic control is still unclear.

Materials and methods

To address this question, we report here the association between pre-infection Haemoglobin A1c (HbA1c) levels and COVID-19 severity as assessed by need for hospitalization in a cohort of 2068 patients with diabetes tested for COVID-19 in Leumit Health Services (LHSs), Israel, between 1 February and 30 April 2020. Using the LHS-integrated electronic medical records system, we were able to collect a large amount of clinical information including age, sex, socio-economic status, weight, height, body mass index, HbA1c, prior diagnosis of ischaemic heart disease, depression/anxiety, schizophrenia, dement

SUBMITTER: Merzon E 

PROVIDER: S-EPMC7460936 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature